methylprednisolone has been researched along with chronic COVID syndrome in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Daniel, J; Fichtner, F; Fischer, AL; Griesel, M; Metzendorf, MI; Mikolajewska, A; Nair, AA; Skoetz, N; Spagl, M; Stegemann, M; Wagner, C | 1 |
1 review(s) available for methylprednisolone and chronic COVID syndrome
| Article | Year |
|---|---|
Systemic corticosteroids for the treatment of COVID-19: Equity-related analyses and update on evidence.
Topics: Adrenal Cortex Hormones; Aged; Aged, 80 and over; COVID-19 Drug Treatment; Dexamethasone; Humans; Invasive Fungal Infections; Methylprednisolone; Post-Acute COVID-19 Syndrome; Randomized Controlled Trials as Topic | 2022 |